Global Retinal Disease Therapeutics Market Overview
Retinal Disease Therapeutics Market was valued at US$ 13.4 Billion in 2024 and is projected to grow at a CAGR of 9.30 % to reach US$ 32.7 Billion by 2034.
Retina is a layer of nerve tissue lining the back of the eye. Retina receives light and converts it into neural signals, and sends these signals to the brain for visual recognition. The central part of the retina is known as macula, which is responsible for central vision. The remaining tissue outside the macula is responsible for peripheral vision. There are many types of retinal diseases. Some of these diseases involve only the macula such as age-related macular degeneration, macular pucker (epiretinal membrane), or macular hole; other diseases can impact the entire retina such as retinal detachment or diabetic retinopathy. The treatment of retinal diseases ranges from administration of eye drops to surgical procedures such as laser therapy, vitreoretinal surgery, and intraocular injection. All these procedures are aimed to preserve the integrity of the retina.
Impact of Covid-19 pandemic on market
With the outbreak of the COVID-19, various businesses are at the forefront to combat this pandemic. The pandemic has hindered the industrial supply chain and also disrupted the product segment. Government across the countries has imposed strict lockdown to limit the spread of disease. Due to the pandemic all the activities are restricted which will adversely impact the retinal disease market. This report will quantify the impact of pandemic on retinal disease therapeutics market.
Global Retinal Disease Therapeutics Market Dynamics
Rise in the incidence of eye-related diseases
There is an alarming rise in the incidence of eye-related diseases, especially in developed countries, which in turn is anticipated to drive the growth of the global retinal drugs market during the forecast period. According to an update from the American Academy of Ophthalmology in 2016, about 93 million people had diabetic retinopathy worldwide, of which 4.2 million patients were from the U.S. Increasing health education initiatives about eye diseases to seek early treatment and prevent visual impairment in emerging regions are further anticipated to fuel the expansion of the global market for retinal drugs during the forecast period.
Increasing awareness about eye disease
Several initiatives have been undertaken across the globe to spread awareness about diagnosis and treatment methods of ophthalmic diseases. The International Centre for Eye Health focuses on increasing awareness about eye health problems and treatment. The World Glaucoma Association has been arranging World Glaucoma Congress for the past six years to increase awareness and discussion about glaucoma treatment advancements. Macular Degeneration Association, Inc. arranges seminars every month across various places to increase treatment penetration for age-related macular degeneration (AMD). These initiatives are expected to increase the adoption of various treatment methods which in turn is projected to fuel the growth of the market.
Global Retinal Disease Therapeutics Market Segmentation
The global retinal disease therapeutics market is segmented based on indication, application and region.
On the basis of indication, the global retinal disease therapeutics market is segmented into Macular Degeneration, Diabetic Macular Edema, Diabetic Retinopathy, and Retinal Vein Occlusion.
Based on application, the global retinal disease therapeutics market is segmented into hospital pharmacy, retail pharmacy, and others.
Regional Insights: 
On region the global retinal disease therapeutics market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to account for a significant share of the market in terms of revenue. High research and development activities in the field of ophthalmic drugs, rising patient population, and high disposable income are factors which are attributed to the high market share of the region. According to data published by Nano Retina (member of the Rainbow Medical Group), in 2014, about 170 million people were affected with AMD worldwide, of which 15 million people were from the U.S. The number of people affected with AMD is expected to reach 288 million by 2040 globally.
Report Scope:
|
Attribute |
Details |
|
Base year for estimation |
2023 |
|
Forecast period |
2024 – 2034 |
|
Market representation |
Revenue in USD Million & CAGR from 2024 – 2034 |
|
Market Segmentation |
By Indication: Macular Degeneration, Diabetic Macular Edema, Diabetic Retinopathy, and Retinal Vein Occlusion By Application: Hospital Pharmacy, Retail Pharmacy, and Others |
|
Delivery Mode Regional scope |
North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa |
|
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered in the Report:
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2019 to 2029. For the purpose of this study, has segmented the global retinal disease therapeutics market report based on indication, application, and region.
Retinal Disease Therapeutics Market, By Indication:
- Macular Degeneration
- Diabetic Macular Edema
- Diabetic Retinopathy
- Retinal Vein Occlusion
Retinal Disease Therapeutics Market, By Application:
- Hospital Pharmacy
- Retail Pharmacy
- Others
Retinal Disease Therapeutics Market, By Region:
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
Global Retinal Disease Therapeutics Market Key Players
The key players operating in the global retinal disease therapeutics market includes Santen Pharmaceutical Co., Ltd., Regeneron Pharmaceuticals, Inc., Shire Plc, Bayer AG, Novartis International AG, Valeant Pharmaceuticals International, Inc., and Merck & Co., Inc. The market is especially characterized by collaborations and partnerships between the businesses and acquisitions of smaller players as a part of strategic expansion as well as launching their new product specimen. For instance, In April 2020, Novartis acquired Amblyotech, a US-based software startup, and will, in collaboration with Ubisoft and McGill University, pursue the development of the acquired digital technology for the treatment of amblyopia.
Global Retinal Disease Therapeutics Market Company Profile
- Santen Pharmaceutical Co., Ltd.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Regeneron Pharmaceuticals, Inc.
- Shire Plc
- Bayer AG
- Novartis International AG
- Valeant Pharmaceuticals International, Inc.
- Merck & Co., Inc.
Global Retinal Disease Therapeutics Market Table of Contents
- Research Objective and Assumption
- Preface
- Research Objectives
- Study Scope
- Years Considered for the study
- Assumptions
- Abbreviations
- Research Methodology
- Research data
- Primary Data
- Primary Interviews
- Primary Breakdown
- Key data from Primary Sources
- Key Thickness Insights
- Secondary Data
- Major Secondary Sources
- Secondary Sources
- Market Estimation
- Top-Down Approach
- Approach for estimating Market Share By Top-Down Analysis (Supply Side)
- Bottom-Up Approach
- Approach for estimating market share By Bottom-up Analysis (Demand Side)
- Market Breakdown and Data Triangulation
- Research Assumptions
- Market Purview
- Executive Summary
- Key Findings—Global Outlook for Retinal Disease Therapeutics Strategies
- Key Questions this Study will Answer
- Market Snippet, By Indication
- Market Snippet, By Application
- Market Snippet, By Region
- Opportunity Map Analysis
- Executive Summary—3 Big Predictions
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- DR Impact Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Opportunity Orbit
- Market Investment Feasibility Index
- Macroeconomic Factor Analysis
- Market Dynamics
- Global Retinal Disease Therapeutics Market, By Indication, 2019 – 2029, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2019 – 2029
- Y-o-Y Growth Analysis (%), 2019 – 2029
- Segment Trends
- Macular Degeneration
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Diabetic Macular Edema
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Diabetic Retinopathy
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Retinal Vein Occlusion
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Overview
- Global Retinal Disease Therapeutics Market, By Application, 2019 – 2029, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2019 – 2029
- Y-o-Y Growth Analysis (%), 2019 – 2029
- Segment Trends
- Hospital Pharmacy
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Retail Pharmacy
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Others
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Overview
- Global Retinal Disease Therapeutics Market, By Region, 2019 – 2029, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2019 – 2029
- Y-o-Y Growth Analysis (%), 2019 – 2029
- Regional Trends
- North America
- Market Size and Forecast (US$ Mn), By Indication, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Application, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
- U.S.
- Canada
- Europe
- Market Size and Forecast (US$ Mn), By Indication, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Application, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Market Size and Forecast (US$ Mn), By Indication, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Application, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast (US$ Mn), By Indication, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Application, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Market Size and Forecast (US$ Mn), By Indication, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Application, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
- GCC
- Israel
- South Africa
- Rest of Middle East
- Overview
- Competitive Landscape
- Heat Map Analysis
- Market Presence and Specificity Analysis
- Company Profiles
-
- Santen Pharmaceutical Co., Ltd.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Business Strategies
- Regeneron Pharmaceuticals, Inc.
- Shire Plc
- Bayer AG
- Novartis International AG
- Valeant Pharmaceuticals International, Inc.
- Merck & Co., Inc.
- Santen Pharmaceutical Co., Ltd.
-
- The Last Word
- Future Impact
- About Us
- Contact
List of Tables
TABLE List of data sources
TABLE Market drivers; Impact Analysis
TABLE Market restraints; Impact Analysis
TABLE Global Retinal Disease Therapeutics Market: Indication Snapshot (2019)
TABLE Segment Dashboard; Definition and Scope, By Indication
TABLE Global Retinal Disease Therapeutics Market, By Indication 2019-2029 (USD Million)
TABLE Global Retinal Disease Therapeutics Market: Application Snapshot (2019)
TABLE Segment Dashboard; Definition and Scope, By Application
TABLE Global Retinal Disease Therapeutics Market, By Application 2019-2029 (USD Million)
TABLE Global Retinal Disease Therapeutics Market: Regional snapshot (2019)
TABLE Segment Dashboard; Definition and Scope, By Region
TABLE Global Retinal Disease Therapeutics Market, By Region 2019-2029 (USD Million)
TABLE North America Retinal Disease Therapeutics Market, By Country, 2019-2029 (USD Million)
TABLE North America Retinal Disease Therapeutics Market, By Indication, 2019-2029 (USD Million)
TABLE North America Retinal Disease Therapeutics Market, By Application, 2019-2029 (USD Million)
TABLE Europe Retinal Disease Therapeutics Market, By Country, 2019-2029 (USD Million)
TABLE Europe Retinal Disease Therapeutics Market, By Indication, 2019-2029 (USD Million)
TABLE Europe Retinal Disease Therapeutics Market, By Application, 2019-2029 (USD Million)
TABLE Asia Pacific Retinal Disease Therapeutics Market, By Country, 2019-2029 (USD Million)
TABLE Asia Pacific Retinal Disease Therapeutics Market, By Indication, 2019-2029 (USD Million)
TABLE Asia Pacific Retinal Disease Therapeutics Market, By Application, 2019-2029 (USD Million)
TABLE Latin America Retinal Disease Therapeutics Market, By Country, 2019-2029 (USD Million)
TABLE Latin America Retinal Disease Therapeutics Market, By Indication, 2019-2029 (USD Million)
TABLE Latin America Retinal Disease Therapeutics Market, By Application, 2019-2029 (USD Million)
TABLE Middle East and Africa Retinal Disease Therapeutics Market, By Country, 2019-2029 (USD Million)
TABLE Middle East and Africa Retinal Disease Therapeutics Market, By Indication, 2019-2029 (USD Million)
TABLE Middle East and Africa Retinal Disease Therapeutics Market, By Application, 2019-2029 (USD Million)
List of Figures
FIGURE Retinal Disease Therapeutics Market segmentation
FIGURE Market research methodology
FIGURE Value chain analysis
FIGURE Porter’s Five Forces Analysis
FIGURE Market Attractiveness Analysis
FIGURE COVID-19 Impact Analysis
FIGURE Pre & Post COVID-19 Impact Comparison Study
FIGURE Competitive Landscape; Key company market share analysis, 2019
FIGURE Indication segment market share analysis, 2019 & 2029
FIGURE Indication segment market size forecast and trend analysis, 2019-2029 (USD Million)
FIGURE Application segment market share analysis, 2019 & 2029
FIGURE Application segment market size forecast and trend analysis, 2019-2029 (USD Million)
FIGURE Regional segment market share analysis, 2019 & 2029
FIGURE Regional segment market size forecast and trend analysis, 2019-2029 (USD Million)
FIGURE North America Retinal Disease Therapeutics Market share and leading players, 2019
FIGURE Europe Retinal Disease Therapeutics Market share and leading players, 2019
FIGURE Asia Pacific Retinal Disease Therapeutics Market share and leading players, 2019
FIGURE Latin America Retinal Disease Therapeutics Market share and leading players, 2019
FIGURE Middle East and Africa Retinal Disease Therapeutics Market share and leading players, 2019
FIGURE North America market share analysis, By country, 2019
FIGURE U.S. Retinal Disease Therapeutics Market size, forecast and trend analysis, 2019-2029 (USD Million)
FIGURE Canada Retinal Disease Therapeutics Market size, forecast and trend analysis, 2019-2029 (USD Million)
FIGURE Europe Retinal Disease Therapeutics Market share analysis, By country, 2019
FIGURE Germany Retinal Disease Therapeutics Market size, forecast and trend analysis, 2019-2029 (USD Million)
FIGURE Spain Retinal Disease Therapeutics Market size, forecast and trend analysis, 2019-2029 (USD Million)
FIGURE Italy Retinal Disease Therapeutics Market size, forecast and trend analysis, 2019-2029 (USD Million)
FIGURE UK Retinal Disease Therapeutics Market size, forecast and trend analysis, 2019-2029 (USD Million)
FIGURE France Retinal Disease Therapeutics Market size, forecast and trend analysis, 2019-2029 (USD Million)
FIGURE Rest of the Europe Retinal Disease Therapeutics Market size, forecast and trend analysis, 2019-2029 (USD Million)
FIGURE Asia Pacific Retinal Disease Therapeutics Market share analysis, By country, 2019
FIGURE India Retinal Disease Therapeutics Market size, forecast and trend analysis, 2019-2029 (USD Million)
FIGURE China Retinal Disease Therapeutics Market size, forecast and trend analysis, 2019-2029 (USD Million)
FIGURE Japan Retinal Disease Therapeutics Market size, forecast and trend analysis, 2019-2029 (USD Million)
FIGURE South Korea Retinal Disease Therapeutics Market size, forecast and trend analysis, 2019-2029 (USD Million)
FIGURE Rest of APAC Retinal Disease Therapeutics Market size, forecast and trend analysis, 2019-2029 (USD Million)
FIGURE Latin America Retinal Disease Therapeutics Market size, forecast and trend analysis, 2019-2029 (USD Million)
FIGURE Latin America Retinal Disease Therapeutics Market share analysis, By country, 2019
FIGURE Brazil Retinal Disease Therapeutics Market size, forecast and trend analysis, 2019-2029 (USD Million)
FIGURE Mexico Retinal Disease Therapeutics Market size, forecast and trend analysis, 2019-2029 (USD Million)
FIGURE Argentina Retinal Disease Therapeutics Market size, forecast and trend analysis, 2019-2029 (USD Million)
FIGURE Rest of LATAM Retinal Disease Therapeutics Market size, forecast and trend analysis, 2019-2029 (USD Million)
FIGURE Middle East and Africa Retinal Disease Therapeutics Market size, forecast and trend analysis, 2019-2029 (USD Million)
FIGURE Middle East and Africa Retinal Disease Therapeutics Market share analysis By country, 2019-2029 (USD Million)
FIGURE Saudi Arabia Retinal Disease Therapeutics Market size, forecast and trend analysis, 2019-2029 (USD Million)
FIGURE United Arab Emirates Retinal Disease Therapeutics Market size, forecast and trend analysis, 2019-2029 (USD Million)
FIGURE Rest of Middle East & Africa Retinal Disease Therapeutics Market size, forecast and trend analysis, 2019-2029 (USD Million)
FAQs
The global retinal disease therapeutics market is segmented based on indication, application and region.
There is an alarming rise in the incidence of eye-related diseases, especially in developed countries, which in turn is anticipated to drive the growth of the global retinal drugs market during the forecast period
North America is expected to account for a significant share of the market in terms of revenue.
The key players operating in the global retinal disease therapeutics market includes Santen Pharmaceutical Co., Ltd., Regeneron Pharmaceuticals, Inc., Shire Plc, Bayer AG, Novartis International AG, Valeant Pharmaceuticals International, Inc., and Merck & Co., Inc.